vs
Koppers Holdings Inc.（KOP）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Koppers Holdings Inc.的1.4倍（$622.0M vs $432.7M），Royalty Pharma plc净利率更高（34.4% vs 6.9%，领先27.6%），Royalty Pharma plc同比增速更快（4.8% vs -9.3%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -6.7%）
科佩斯控股是一家全球性化工与材料企业，总部位于美国宾夕法尼亚州匹兹堡，入驻建于1920年代的装饰艺术风格摩天大楼科佩斯大厦，在全球范围内开展相关业务经营。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
KOP vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.4倍
$432.7M
营收增速更快
RPRX
高出14.1%
-9.3%
净利率更高
RPRX
高出27.6%
6.9%
两年增速更快
RPRX
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $432.7M | $622.0M |
| 净利润 | $29.7M | $214.2M |
| 毛利率 | 25.6% | — |
| 营业利润率 | 11.5% | 62.4% |
| 净利率 | 6.9% | 34.4% |
| 营收同比 | -9.3% | 4.8% |
| 净利润同比 | 391.2% | 2.9% |
| 每股收益（稀释后） | $1.44 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KOPRPRX
| Q4 25 | $432.7M | $622.0M | ||
| Q3 25 | $485.3M | $609.3M | ||
| Q2 25 | $504.8M | $578.7M | ||
| Q1 25 | $456.5M | $568.2M | ||
| Q4 24 | $477.0M | $593.6M | ||
| Q3 24 | $554.3M | $564.7M | ||
| Q2 24 | $563.2M | $537.3M | ||
| Q1 24 | $497.6M | $568.0M |
净利润KOPRPRX
| Q4 25 | $29.7M | $214.2M | ||
| Q3 25 | $23.8M | $288.2M | ||
| Q2 25 | $16.4M | $30.2M | ||
| Q1 25 | $-13.9M | $238.3M | ||
| Q4 24 | $-10.2M | $208.2M | ||
| Q3 24 | $22.8M | $544.0M | ||
| Q2 24 | $26.8M | $102.0M | ||
| Q1 24 | $13.0M | $4.8M |
毛利率KOPRPRX
| Q4 25 | 25.6% | — | ||
| Q3 25 | 24.1% | — | ||
| Q2 25 | 22.6% | — | ||
| Q1 25 | 23.2% | — | ||
| Q4 24 | 17.5% | — | ||
| Q3 24 | 21.9% | — | ||
| Q2 24 | 21.6% | — | ||
| Q1 24 | 19.3% | — |
营业利润率KOPRPRX
| Q4 25 | 11.5% | 62.4% | ||
| Q3 25 | 10.7% | 70.1% | ||
| Q2 25 | 7.7% | 36.3% | ||
| Q1 25 | 5.9% | 94.0% | ||
| Q4 24 | 1.3% | 60.9% | ||
| Q3 24 | 9.0% | — | ||
| Q2 24 | 10.2% | 50.2% | ||
| Q1 24 | 7.0% | -13.0% |
净利率KOPRPRX
| Q4 25 | 6.9% | 34.4% | ||
| Q3 25 | 4.9% | 47.3% | ||
| Q2 25 | 3.2% | 5.2% | ||
| Q1 25 | -3.0% | 41.9% | ||
| Q4 24 | -2.1% | 35.1% | ||
| Q3 24 | 4.1% | 96.3% | ||
| Q2 24 | 4.8% | 19.0% | ||
| Q1 24 | 2.6% | 0.8% |
每股收益（稀释后）KOPRPRX
| Q4 25 | $1.44 | $0.49 | ||
| Q3 25 | $1.17 | $0.67 | ||
| Q2 25 | $0.81 | $0.07 | ||
| Q1 25 | $-0.68 | $0.55 | ||
| Q4 24 | $-0.47 | $0.46 | ||
| Q3 24 | $1.09 | $1.21 | ||
| Q2 24 | $1.25 | $0.23 | ||
| Q1 24 | $0.59 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | $928.3M | $9.0B |
| 股东权益账面价值 | $574.0M | $9.7B |
| 总资产 | $1.9B | $19.6B |
| 负债/权益比越低杠杆越低 | 1.62× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资KOPRPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $843.0M |
总债务KOPRPRX
| Q4 25 | $928.3M | $9.0B | ||
| Q3 25 | $932.9M | $8.9B | ||
| Q2 25 | $977.5M | $8.0B | ||
| Q1 25 | $989.0M | $7.6B | ||
| Q4 24 | $939.5M | $7.6B | ||
| Q3 24 | $989.4M | $7.6B | ||
| Q2 24 | $1.0B | $7.6B | ||
| Q1 24 | $877.6M | $6.1B |
股东权益KOPRPRX
| Q4 25 | $574.0M | $9.7B | ||
| Q3 25 | $545.6M | $9.6B | ||
| Q2 25 | $526.8M | $9.5B | ||
| Q1 25 | $498.0M | $9.8B | ||
| Q4 24 | $488.7M | $10.3B | ||
| Q3 24 | $532.3M | $10.3B | ||
| Q2 24 | $509.2M | $9.8B | ||
| Q1 24 | $505.8M | $9.9B |
总资产KOPRPRX
| Q4 25 | $1.9B | $19.6B | ||
| Q3 25 | $1.9B | $19.3B | ||
| Q2 25 | $1.9B | $18.3B | ||
| Q1 25 | $1.9B | $17.6B | ||
| Q4 24 | $1.9B | $18.2B | ||
| Q3 24 | $2.0B | $18.0B | ||
| Q2 24 | $1.9B | $17.7B | ||
| Q1 24 | $1.8B | $16.1B |
负债/权益比KOPRPRX
| Q4 25 | 1.62× | 0.92× | ||
| Q3 25 | 1.71× | 0.93× | ||
| Q2 25 | 1.86× | 0.84× | ||
| Q1 25 | 1.99× | 0.78× | ||
| Q4 24 | 1.92× | 0.74× | ||
| Q3 24 | 1.86× | 0.74× | ||
| Q2 24 | 1.97× | 0.78× | ||
| Q1 24 | 1.74× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $28.5M | — |
| 自由现金流率自由现金流/营收 | 6.6% | — |
| 资本支出强度资本支出/营收 | 3.8% | — |
| 现金转化率经营现金流/净利润 | 1.52× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $67.5M | — |
8季度趋势，按日历期对齐
经营现金流KOPRPRX
| Q4 25 | $45.1M | $827.1M | ||
| Q3 25 | $49.6M | $702.6M | ||
| Q2 25 | $50.5M | $364.0M | ||
| Q1 25 | $-22.7M | $596.1M | ||
| Q4 24 | $74.7M | $742.5M | ||
| Q3 24 | $29.8M | $703.6M | ||
| Q2 24 | $27.2M | $658.2M | ||
| Q1 24 | $-12.3M | $664.6M |
自由现金流KOPRPRX
| Q4 25 | $28.5M | — | ||
| Q3 25 | $37.6M | — | ||
| Q2 25 | $38.4M | — | ||
| Q1 25 | $-37.0M | — | ||
| Q4 24 | $56.1M | — | ||
| Q3 24 | $14.4M | — | ||
| Q2 24 | $10.1M | — | ||
| Q1 24 | $-38.6M | — |
自由现金流率KOPRPRX
| Q4 25 | 6.6% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 7.6% | — | ||
| Q1 25 | -8.1% | — | ||
| Q4 24 | 11.8% | — | ||
| Q3 24 | 2.6% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | -7.8% | — |
资本支出强度KOPRPRX
| Q4 25 | 3.8% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 3.1% | — | ||
| Q4 24 | 3.9% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 5.3% | — |
现金转化率KOPRPRX
| Q4 25 | 1.52× | 3.86× | ||
| Q3 25 | 2.08× | 2.44× | ||
| Q2 25 | 3.08× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 1.31× | 1.29× | ||
| Q2 24 | 1.01× | 6.45× | ||
| Q1 24 | -0.95× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KOP
| Other | $127.8M | 30% |
| Railroad Treated Products | $119.0M | 28% |
| Utility Poles | $79.8M | 18% |
| Pitch And Related Products | $74.1M | 17% |
| Carbon Black Feedstock And Distillates | $14.4M | 3% |
| Railroad Infrastructure Products And Services | $9.9M | 2% |
| Phthalic Anhydride Naphthalene And Other Chemicals | $7.7M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
